In others, it may not provide the benefits you are hoping for
While Ozempic and Rybelsus are prescribed off-label for weight loss, this can impact their coverage eligibility
Buyer Takeaway: Realistic expectations: meaningful weight loss is possible with GLP-1 medications for eligible patients who commit to the full program, including lifestyle support components
2022 R&D Spend: In 2022, Merck KGaA (Life Science and Healthcare divisions only) spent 2.02 billion ($2.13 billion USD) on R&D, a 1.70 percent decrease from the 2.06 billion ($2.43 billion USD) the companys Life Science and Healthcare divisions spent on R&D in 2021
For health plans including these drugs on their prescription drug formularies, utilization management tools, like prior authorization and step therapy, can be used to allow medically indicated access to the drugs while controlling costs by tying coverage of the drugs to specific clinical and treatment criteria